Dispelling Myths About Suboxone Withdrawal and Suboxone Treatment

Dispelling Myths About Suboxone Withdrawal and Suboxone Treatment

Suboxone is a medication that has been approved by the FDA to treat addiction to opiates – prescription pain pills such as Oxycodone, Oxycontin,
Percocet, Vicodin and heroin and fentanyl. Buprenorphine is a long-acting, high-affinity partial agonist at the mu opioid receptor. It prevents withdrawal symptoms and craving and stabilizes the opioid receptors. It blocks other opioids from binding to the opioid receptors preventing abuse of other opioids. It also does not intoxicate the user. Fortunately Suboxone withdrawal management and Suboxone treatment in New Jersey are
available at many locations: Warren county, Middlesex county, Essex county, Bergen county, Monmouth county, Somerset county, Ocean
county, Hunterdon county, Union county, Hudson county, Salem county, Mercer county, Passaic county, Morris county, Sussex county, Atlantic
county, etc.

While the primary ingredient in Suboxone is buprenorphine, it also contains a small amount of naloxone. Buprenorphine directly mitigates opiate withdrawal symptoms and cravings, while naloxone prevents an overdose in the event that the patient being treated with Suboxone for opiate dependency relapses on opiates. The role of naloxone in the medication cannot be overemphasized. When a patient who is dependent on opiates stops its use and instead utilizes Suboxone (or other variants) to eliminate withdrawal symptoms and cravings, their tolerance for opiates decreases quickly. In the event the patient relapses on opiates and uses the same quantity or dosage of opiates as before starting treatment, they could overdose due to reduced tolerance for the drug. The Naloxone in the Suboxone sharply reduces the probability of overdose by preventing the opiates from binding to the opiate receptors.

As per the National Institute of Health, buprenorphine significantly lowers the risk of mortality and adverse outcomes. Buprenorphine is superior to methadone for tolerability, but equivalent in effectiveness. Patients on maintenance buprenorphine after detox, also known as MAT, had lower
rates of HIV and hepatitis transmission.

Buprenorphine can be abused when used intravenously or intranasally. The buprenorphine + naloxone combination, such as in Suboxone, ensures that buprenorphine is not abused. Despite the proven efficacy of buprenorphine in treating addiction to opiates, it is not a panacea.
Medication assisted treatment, or MAT utilizing buprenorphine needs to be combined with therapy so that needed life style changes can be effected in order to facilitate long-term recovery. Buprenorphine molecules bind with the same receptors in the brain as opium and other intoxication inducing drugs like heroin, fentanyl, morphine, and oxycodone. Therefore, there are many misconceptions about Suboxone and buprenorphine, the main one being that it is a “drug-for-drug” substitution, so it does not really address the addiction.

Here are some misconceptions about Suboxone:

Medication Assisted Treatment or MAT, utilizing Suboxone or buprenorphine is substituting one drug for another

Suboxone and buprenorphine are FDA approved medications, and, if used, as prescribed, it is not a substance of abuse. They are stable, safe, long-
acting medications with a ceiling effect. They do not deliver a high.

Utilizing Suboxone or buprenorphine is so much safer than just using willpower because it reduces cravings and fully addresses opiate withdrawal symptoms, significantly lowering the probability of a relapse.

Utilizing Suboxone or buprenorphine is equivalent to capitulating

Addiction is a disease and not a moral failure or a behavioral problem. Changes in the brain caused by addiction take years to repair leaving the individual afflicted by addiction susceptible to relapse. Medication Assisted Treatment, or MAT, utilizing Suboxone or buprenorphine provides the physical comfort and stability needed to effect lifestyle changes needed to maintain long-term recovery.

Suboxone or buprenorphine are incompatible with self-help groups

Self-help groups have come a long way in terms of accepting approved medications taken as prescribed. The renowned Hazeldon Betty Ford Foundation has pioneered the integration of partial agonist therapy with 12-step, self-help groups. Despite progress there is some resistance within AA and NA to accept buprenorphine and suboxone maintenance treatment.

The Center for Network Therapy is a premier addiction treatment provider in New Jersey and provides Suboxone withdrawal management and Suboxone treatment at all of its locations in New Jersey: West Orange, Middlesex and Freehold.

Suboxone and buprenorphine can deliver a high

Buprenorphine and Suboxone have a ceiling effect and cannot deliver a high. Some patients have reported feelings of mild euphoria, but it is not
substantiated. These are FDA approved medications and patients are safe to drive and operate machinery while on these medications and patients’
cognitive function is likely improved compared to other opioid users. A ‘high’ can only be obtained when patients combine Suboxone with other
substances or use it to medicate withdrawal between episodes of abusing opiates such as heroin, fentanyl or prescription pain pills such as Percocet, Oxycontin, Oxycodone, or other opiates.

Suboxone has a cash market on the street

While it is true that Suboxone is a valuable commodity on the street and can be exchanged for food, sex or drugs, diligent monitoring of suboxone
consumption through urine testing can deliver optimal results. Prescriptions need to maintained at 2 weeks in the initial stages and lengthened to no more than 4 weeks after the patient has proven to be serious about his or her recovery. Also, the rates of diversion for Suboxone has been similar to that of antibiotics.

Suboxone Treatment, A Net Positive

Suboxone treatment in New Jersey is easy to access. The Center for Network therapy has a location in Middlesex in Middlesex County, West Orange in Essex county and Freehold in Monmouth county. Suboxone treatment in New Jersey and other parts of the country have been proven to deliver better outcomes for those suffering from an addiction to opiates – the benefits far outweigh any risks associated with Suboxone. Some people do develop a physical and psychological dependence to Suboxone, but the real physical withdrawal symptoms are mild and can be addressed easily.

The good news for residents of New Jersey is that management of Suboxone withdrawal and treatment utilizing Suboxone are available in several location in New Jersey: Marlboro, West Orange, Far Hills, Short Hills, Warren, Freehold, Manalapan, Middlesex, Union, Westfield, Livingston, Chatham, Madison, Hackensack, Jersey City, Bridgewater, Bedminster, Morristown, Newton, Pine Brook, Montville, Nutley, Ridgewood, Montclair, Toms River, Lakewood, Cherry Hill, Trenton, Newark, East Orange, Mendham, Chester, Metuchen, Edison, New Brunswick, Matawan, Paramus, Upper Saddle River, etc.

Conclusion

Suboxone and buprenorphine remain one of the most optimal treatment for opioid addiction. They are FDA approved medications that are safe and effective and do not deliver a high as wrongly assumed by many. However, Suboxone therapy has to be combined with therapy such as CBT or DBT in order to achieve the best possible results. Fortunately, over the years, resistance to this medication has fallen from self-help groups such as AA and NA helping more people addicted to opiates to utilize suboxone maintenance therapy and still access self-help groups that are so critical to maintaining long-term sobriety.

Insurance

In-network with:

Aetna
AmeriHealth
Anthem BCBS
Beacon Health Options
Emblem BCBS
GHI
Empire BCBS
Horizon BCBS (EPO, HMO, PPO)
Oscar
QualCare
United Health/Optum/Oxford
Emblem GHI*
Humana*

 

* If the QualCare logo is on the
insurance card